4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-22-019051
Chief Scientific Officer sold 4,415 shares at $1.53 ($6,755)
- Chief Scientific Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loose Christopher R. · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-05 | Exercise or conversion : show line 1 in the form | +15,000 | 54,465 | D | ||
| 2022-07-06 | Sale : show line 2 in the form | −4,415 | $1.53 | $6,755 | 50,050 | D |
| Open-market sales · 4,415 sh · avg $1.53 · $6,755 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2022-07-05 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −15,000 | 15,000 | 0 | D |
Loading xslF345X03/form4.xml…